Philips 2007 Annual Report Download - page 60

Philips Annual Report 200766
Support care providers throughout the entire
care cycle by developing disease-based product
and service solutions
Cardiology
Philips innovations are driving integration of cardiology
products and services, bridging previously disparate
cardiac
patient events, from arrival at healthcare facilities,
through transfers to non-invasive, interventional intensive
care. This process is supported by one of the broadest
cardiology portfolios on the market, encompassing
multi-disciplinary diagnoses and inclusive treatments,
with fewer mistakes and repeated procedures. Our goal
is the delivery of better, more efcient care through earlier
diagnosis, fewer disabilities, faster recoveries and, in cases
of long-term care, slower progression of disease.
By way of example, in 2007 Philips introduced its HeartStart
MRx Monitor/Debrillator, which enables paramedics to
transmit patient data from the ambulance to the hospital’s
emergency department. By allowing a hospital to begin
organizing its resources before the patient arrives, the MRx
can help reduce the time to treatment.
Another example of how Philips optimizes timely delivery
of diagnosis and treatment in the cardiac care cycle is the
recently introduced ultrasound transducer for Live 3D
transesophageal echocardiography (Live 3D TEE), which
provides views of cardiac structure and function available
for the rst time. Along with new advanced software, this
enables 2D imaging as well as real-time 3D visualization
of the heart, in particular the heart’s valves, giving
clinicians the ability to carry out a complete analysis,
which allows a faster, more precise diagnosis.
Oncology
Our commitment in oncology is to provide technologies
and support that enable physicians to make effective
treatment decisions for cancer patients at every point
of care. As our collective understanding of how to detect,
stage and treat cancer continues to evolve, so does our
ability to detect disease earlier, to stage disease more
accurately and to pursue image-guided interventional
treatment techniques.
Clinical insights in the treatment of oncology patients
led to the 2007 introduction of the GEMINI Big Bore
PET-CT to complement the Brilliance Big Bore CT.
This offering allows radiation oncologists to see both
the biological cell intensity combined with anatomical
tumor location in the treatment position, and where
With regard to sourcing, please refer to the business
description of Philips Supply Management that begins
on page 96 of this Annual Report.
Progress against targets
The Annual Report 2006 set out a number of key targets
for Medical Systems in 2007. The advances made in
addressing these are outlined below.
Continue to grow faster than the market
We continued to grow slightly faster than the market
by: intensifying the focus on emerging market growth,
resulting in double-digit order intake growth in China,
India and Latin America; maintaining the solid innovation
rate and further increasing service-contract penetration
by slightly more than 2%; and making strategically
aligned acquisitions.
In 2007 we continued to broaden our position in
strategic growth areas and increased penetration into
international markets through focused investments
in products and channels.
The acquisition of XIMIS, a company that focuses on
systems to help reduce medical errors and streamline
workow in hospitals, further expands our growing
presence in the radiology informatics market. This was
followed by the announcement, toward the end of the
year, of the acquisitions of the US-based clinical IT
specialists Emergin (closed in 2007) and VISICU (to
be nalized in 2008), enhancing our capability to offer
full monitoring solutions.
In line with the strategy to bolster our healthcare presence
in emerging markets, we acquired Brazil’s leading general
X-ray manufacturer, VMI-Sistemas Medicos, thereby
expanding our position in the Latin American market.
We also entered into a number
of strategic agreements,
e.g. with Artemis Health Institute
in Gurgaon, India,
to supply medical equipment and undertake integrated
medical technology planning as well as research and
development, enabling Philips to capture real-time
scientic data.
8 Financial highlights 10 Message from the President 16 The Philips Group 62 The Philips sectors
Medical Systems